Cancer Biology & Medicine: 21 (10)

October 15, 2024; Volume 21,Issue 10

Editorials

Open Access
Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment
Zhihong Luo and Ke Gong

Cancer Biology & Medicine October 2024, 21 (10) 831-837; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0327
Open Access
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China
Jianbin Li and Zefei Jiang

Cancer Biology & Medicine October 2024, 21 (10) 838-843; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0374

Open Access
Personalized laparoscopic radical resection of gallbladder cancer by staining of the liver draining area through ICG injection into the cholecystic artery
Xu Bao, Dongyang Li and Wei Zhang

Cancer Biology & Medicine October 2024, 21 (10) 844-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0206

Open Access
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Mao Zhang, Haokai Qin, Yingcheng Wu and Qiang Gao

Cancer Biology & Medicine October 2024, 21 (10) 849-863; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0192
Open Access
Artificial intelligence strengthens cervical cancer screening – present and future
Tong Wu, Eric Lucas, Fanghui Zhao, Partha Basu and Youlin Qiao

Cancer Biology & Medicine October 2024, 21 (10) 864-879; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0198
Open Access
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies
Jianlin Shen, Yue Lai, Yanjiao Wu, Xuan Lin, Cheng Zhang and Huan Liu

Cancer Biology & Medicine October 2024, 21 (10) 880-897; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0231
Open Access
Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review
Xiaoning Gan, Guanqi Dai, Yonghao Li, Lin Xu and Guolong Liu

Cancer Biology & Medicine October 2024, 21 (10) 898-915; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0224

Open Access
Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p
Yan Zhuang, Yiding Ai, Peng Li, Xin Yue, Yue Li, Luling Shan, Tongtong Wang, Peng Zhao and Xun Jin

Cancer Biology & Medicine October 2024, 21 (10) 916-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0112
Open Access
Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2– advanced breast cancer
Qi Zhao, Mingxia Jiang, Jiaxuan Liu, Mengqi Zhang, Maiyue He, Shihan Zhou, Jiani Wang, Hongnan Mo, Bo Lan, Peng Yuan, Pin Zhang, Fei Ma, Qiao Li and Binghe Xu

Cancer Biology & Medicine October 2024, 21 (10) 934-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0204
Open Access
Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial
Cuicui Zhang, Tianqing Chu, Qiming Wang, Ying Cheng, Yongxiang Zhang, Ruili Wang, Leilei Ma, Chaonan Qian, Baohui Han and Kai Li

Cancer Biology & Medicine October 2024, 21 (10) 951-962; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0423